Associate Professor of Obstetrics and Gynecology The Ohio State University and James CCC; Director, Clinical Research Gynecologic Oncology; ORIEN Physician Liaison for OSUCCC-James
Obstetrics & Gynecology
Dr. David M. O'Malley, MD
|
|
Give Review
Dr. David M. O'Malley works in the field of Obstetrics & Gynecology. He graduated from Wayne State University School of Medicine. Wayne State University School of Medicine has a rank of 63 in research and a 85 in primary care He received 2 awards: "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". David M. O'Malley is a published MD as well. He has 52 publications published. The latest was: Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMI.
Publications
- Reply to G.B. Holt.
- Survival outcomes of obese patients in type II endometrial Cancer: Defining the prognostic impact of increasing BMI.
- A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive Ovarian, primary peritoneal, and fall...
- The Use of Transvaginal Ultrasound in Type II Endometrial Cancer.
- Randomized Phase III Trial of Gemcitabine Plus Docetaxel Plus Bevacizumab or Placebo As First-Line Treatment for Metastatic Uterine Leiomyosarcoma: An NRG Oncology/Gyn...
- Predicting Inpatient Stay Lasting Two Midnights or More after Robotic Surgery for Endometrial Cancer.
- Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated Cervical, vaginal, or vulvar cancer?
- Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin.
- A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian Cancer.
- Is bariatric surgery an option for women with gynecologic Cancer? Examining weight loss counseling practices and training among gynecologic oncology providers.
- A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group study.
- Feasibility of Interval Cytoreduction Following Neoadjuvant Chemotherapy With Carboplatin, Weekly Paclitaxel, and Bevacizumab for Advanced Ovarian Cancer-A Phase 1 Study.
- Reducing Readmissions after Robotic Surgical Management of Endometrial Cancer: A Potential for Improved Quality Care.
- Ovarian Cancer, version 2.2013.
- Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian Cancer?
- Analysis of disease recurrence and survival for women with Uterine malignancies undergoing robotic surgery.
- Outcomes following percutaneous upper gastrointestinal decompressive tube placement for malignant bowel obstruction in ovarian Cancer.
- A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial Cancer.
- The impact of close surgical margins after radical hysterectomy for early-stage Cervical cancer.
- Here it comes....the role of cost-effective analysis.
- Short- and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial Cancer staging.
- Uterine Serous Carcinoma: Increased Familial Risk for Lynch-Associated Malignancies.
- Response to letter to the editor in response to "Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated re...
- Phase II Evaluation of Phenoxodiol in Combination With Cisplatin or Paclitaxel in Women With Platinum/Taxane-Refractory/Resistant Epithelial Ovarian, Fallopian Tube, o...
- Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian Cancer.
- At what cost does a potential survival advantage of bevacizumab make sense for the primary treatment of ovarian Cancer? A cost-effectiveness analysis.
- Epithelial ovarian Cancer.
- Is there a high-risk subgroup of stage I epithelial ovarian Cancer that is most likely to benefit from 6 versus 3 cycles of adjuvant chemotherapy?
- Efficacy and safety of imatinib mesylate (Gleevec) and immunohistochemical expression of c-Kit and PDGFR-beta in a Gynecologic Oncology Group Phase Il Trial in women w...
- Stage I, grade 3 endometrioid adenoCarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence.
- Outpatient platinum-taxane intraperitoneal chemotherapy regimen for ovarian Cancer.
- Prospective evaluation of DNA mismatch repair protein expression in primary endometrial Cancer.
- A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial Cancer.
- Multicenter analysis of recurrence and survival in stage IIIA endometrial Cancer.
- Brain metastases in epithelial ovarian and primary peritoneal Carcinoma.
- Paratubal borderline serous tumors.
- Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenoCarcinoma.
- Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian Cancer.
- Local correction of extreme stomal Prolapse following transverse loop colostomy.
- Stage IV endometrial Cancer after failed conservative management: a case report.
- Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian Cancer.
- CA125 decline in ovarian Cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy.
- Atypical presentations of carboplatin hypersensitivity reactions: characterization and management in patients with gynecologic malignancies.
- Improved survival in surgical stage I patients with uterine papillary serous Carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.
- Weekly topotecan in heavily pretreated patients with recurrent epithelial ovarian Carcinoma.
- Minimal uterine serous Carcinoma: a clinicopathological study of 40 cases.
- Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced Cervical cancer.
- A comprehensive overview of radioguided surgery using gamma detection probe technology.
- Stage II uterine papillary serous Carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes.
- Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous Carcinoma.
- An updated clinicopathologic study of early-stage uterine papillary serous Carcinoma (UPSC).
Schools
Wayne State University School Of Medicine
Cleveland Clinic
Metropolitan Health Med Center
Yale University School Med
Procedures Preformed
- Colposcopy
- Contraceptive Management
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- Destruction or Excision of Vaginal Lesions
- View All
Conditions Treated
- Atrophic Vaginitis
- Carcinoma in Situ
- Cervical Cancer
- Cervical Polyps
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
Yale University School of Medicine -
Case Western Reserve University - MetroHealth -
Cleveland Clinic Foundation -
Wayne State University School of Medicine
Hospital
-
Ohio State University Wexner Medical Center
Drug Facts
| NPI NUMBER | 1609819424 | |
| NPPES Provider LastName | O'MALLEY | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 430267752 | |
| NPPES Provider State | OH | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 229.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 5.68 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609819424 |
| Last Name Of The Provider | O'MALLEY |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
Dr. Gary C. Reid, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Larry Simon, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeffrey M. Fowler, MD |
|
Dr. Larry J. Copeland, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carol S. Jenkins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathleen Q. Lutter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey G. Bell, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kellie Rath, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Chad I. Friedman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Basil V. Bisca, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Garth F. Essig Sr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Delois Teague, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David E. Cohn, MD |
|
Dr. Melissa M. Goist, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George S. Lewandowski, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jacqueline T. Rohl, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manupreet K. Chawla, MD |
|
|
Dr. Courtney A. Abshier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kara B. Markham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cynthia S. Shellhaas, MD
This Doctor is OpenDoctor Recommended.
|